Critical Elements of the Immunoglobulin Heavy Chain Gene Enhancers for Deregulated Expression of Bcl-2

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6666-6673

  Heckman, Caroline A ^a   Cao, Thai ^a   Somsouk, Lina ^a   Duan, Hong ^a   Mehew, John W ^a   Zhang, Chun Yi ^a   Boxer, Linda M ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BCL 2; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; CELL DEATH; CONTROLLED STUDY; DEREGULATION; ENHANCER REGION; FOLLICULAR LYMPHOMA; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN INTERACTION; UPREGULATION;

BINDING SITES; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, IMMUNOGLOBULIN; HUMANS; LYMPHOMA, B-CELL; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-BCL-2; SP1 TRANSCRIPTION FACTOR; TRANSFECTION; TRANSLOCATION, GENETIC;

EID: 0142188733     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Cleary, M. L., Smith, S. D., and Sklar, J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47: 19-28, 1986.
2. Tsujimoto, Y., and Croce, C. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83: 5214-5218, 1986.
3. Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E., and Croce, C. M. The t(14;18) chromosome translocations involved in B-cell neoplasms result front mistakes in VDJ joining. Science (Wash. DC). 229: 1390-1393, 1985.
4. Hockenberry, D., Nunez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348: 334-336, 1990.
5. Vaux, D. L., Cory, S., and Adams, J. M. Bcl-2 gene promotes hacmopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335: 440-442, 1988.
6. Desoize, B. Anticancer drug resistance and inhibition of apoptosis. Anticancer Res., 14: 2291-2294, 1994.
7. Reed, J. C., Kitada, S., Takayama, S., and Miyashita, T. Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines. Ann. Oncol., 5 (Suppl. 1): S61-S65, 1994.
8. Schmitt, C. A., and Lowe, S. W. Bcl-2 mediates chemoresistance in matched pairs of primary Eμ-myc lymphomas in vivo. Blood Cells Mol. Dis., 27: 206-216, 2001.
9. Schmitt, C. A., Rosenthal, C. T., and Lowe, S. W. Genetic analysis of chemoresistance in primary murine lymphomas. Nat. Med., 6: 1029-1035, 2000.
10. Ji, L., Mochon, E., Arcinas, M., and Boxer, L. M. CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas. J. Biol. Chem., 271: 22687-22691, 1996.
11. Wilson, B. E., Mochon, E., and Boxer, L. M. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol. Cell. Biol., 16: 5546-5556, 1996.
12. Heckman, C. A., Mehew, J. W., and Boxer, L. M. NF-κB activates bcl-2 expression in t(14;18) lymphoma cells. Oncogene, 21: 3898-3908, 2002.
13. Riccio, A., Ahn, S., Davenport, C. M., Blendy, J. A., and Ginty, D. D. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science (Wash. DC), 286: 2358-2361, 1999.
14. Huang, H., Cheville, J. C., Pan, Y., Roche, P. C., Schmidt, L. J., and Tindall, D. J. PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of bcl-2 expression. J. Biol. Chem., 276: 38830-38836, 2001.
15. Mehrhof, F. B., Muller, F. U., Bergmann, M. W., Li, P., Wang, Y., Schmitz, W., Dietz, R., and von Harsdorf, R. In cardiomyocyte hypoxia, insulin-like growth factor-1-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. Circulation, 104: 2088-2094, 2001.
16. Dong, L., Wang, W., Wang, F., Stoner, M., Reed, J. C., Harigai, M., Samudio, I., Kladde, M. P., Vyhlidal, C., and Sale, S. Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells. J. Biol. Chem., 274: 32099-32107, 1999.
17. Pugazhenthi, S., Miller, E., Sable, C., Heidenreich, K. A., Boxer, L. M., and Reusch, J. E. B. Insulin-like growth factor induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein. J. Biol. Chem., 274: 27529-27535, 1999.
18. Pugazhenthi, S., Nesterova, A., Sable, C., Heidenreich, K. A., Boxer, L. M., Heasley, L. E., and Reusch, J. E. B. Akt/protein kinase B up-regulates bcl-2 expression through cAMP-response element-binding protein. J. Biol. Chem., 275: 10761-10766, 2000.
19. Heckman, C., Mochon, E., Arcinas, M., and Boxer, L. M., The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas. J. Biol. Chem., 272: 19609-19614, 1997.
20. Hewitt, S. M., Hamada, S., McDonnell, T. J., Rauscher, F. J. I., and Saunders, G. F, Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene, WT1. Cancer. Res., 55: 5386-5389, 1995.
21. Mayo, M. W., Wang, C. Y., Drouin, S. S., Madrid, L. V., Marshall, A. F., Reed, J. C., Weissman, B. E., and Baldwin, A. S. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. EMBO J., 18: 3990-4003, 1999.
22. Arulampalam, V., Eckhardt, L., and Pettersson, S. The enhancer shift: a model to explain the developmental control of IgH gene expression in B-lineage cells. Immunol. Today, 18: 549-554, 1997.
23. Madisen, L., and Groudine, M. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Genes Dev., 8: 2212-2226, 1994.
24. Michaelson, J. S., Giannini, S. L., and Birshtein, B. K. Identification of 3′α-hs4, a novel Ig heavy chain enhancer element regulated at multiple stages of B cell differentiation. Nucleic Acids Res., 23: 975-981, 1995.
25. Pettersson, S., Cook, G. P., Bruggemann, M., Williams, G. T., and Neuberger, M. S. A second B cell-specific enhancer 3′ of the immunoglobulin heavy chain locus. Nature (Lond.), 344: 165-168, 1990.
26. Saleque, S., Singh, M., Litter, R. D., Giannini, S. L., Michaelson, J. S., and Birshtein, B. K. Dyad symmetry within the mouse 3′ IgH regulatory region includes two virtually identical enhancers (C α3′E and hs3). J. Immunol., 158: 4780-4787, 1997.
27. Chauveau, C., Pinaud, E., and Cogne, M. Synergies between regulatory elements of the immunoglobulin heavy chain locus and its palindromic 3′ locus control region. Eur. J. Immunol., 28: 3048-3056, 1998.
28. Ong, J., Stevens, S., Roeder, R. G., and Eckhardt, L. A. 3′ Immunoglobulin heavy chain enhancer elements shift synergistic interactions during B cell development. J. Immunol., 160: 4896-4903, 1998.
29. Chen, C., and Birshtein, B. K. Virtually identical enhancers containing a segment of homology to marine 3′ [gH-E(hs1,2) lie downstream of human Ig Cα1 and Cα2 genes. J. Immunol., 159: 1310-1318, 1997.
30. Mills, F., Harindranath, N., Mitchell, M., and Max, E. Enhancer complexes located downstream of both human immunoglobulin C α genes. J. Exp. Med., 186: 845-858, 1997.
31. Pinaud, E., Aupetit, C., Chauveau, C., and Cogne, M. Identification of a homolog of the Cα3′/hs3 enhancer and of an allelic variant of the 3′IgH/hs1,2 enhancer downstream of the human immunoglobulin α1 gene. Eur. J. Immunol., 27: 2981-2985, 1997.
32. Laurencikiene, J., Deveikaite, V., and Severinson, E. HS1,2 enhancer regulation of germline ε and γ2b promoters in murine 8 lymphocytes: evidence for specific promoter-enhancer interactions. J. Immunol., 167: 3257-3265, 2001.
33. Michaelson, J. S., Singh, M., Snapper, C. M., Sha, W. C., Baltimore, D., and Birshtein, B. K. Regulation of 3′ IgH enhancers by a common set of factors, including κB-binding proteins. J. Immunol., 156: 2828-2839, 1996.
34. Zelazowski, P., Shen, H., and Snapper, C. M. NF-kB/p50 and NF-kB/c-Rcl differentially regulate the activity of the 3′αE-hs1,2 enhancer in normal murine B cells in an activation-dependent manner. Int. Immunol., 12: 1167-1172, 2000.
35. Singh, M., and Birshtein, B. K. NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3′α enhancer at early stages of B-cell differentiation. Mol. Cell. Biol., 13: 3611-3622, 1993.
36. Singh, M., and Birshtein, B. K. Concerted repression of an immunoglobulin heavy-chain enhancer, 3′αE(hs1,2). Proc. Natl. Acad. Sci. USA, 93: 4392-4397, 1996.
37. Muto, A., Hoshino, H., Madisen, L., Yanai, N., Obinata, M., Karasuyama, H., Hayashi, N., Nakauchi, H., Yamamoto, M., Groudine, M., and Igarashi, K. Identification of Bach2 as a B-cell specific partner for small Maf proteins that negatively regulate the immunoglobulin heavy chain gene 3′ enhancer. EMBO J., 17: 5734-5743, 1998.
38. Grant, P. A., Thompson, C. B., and Pettersson, S. IgM receptor mediated transactivation of the IgH 3′ enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function. EMBO J., 14: 4501-4513, 1995.
39. Grant, P. A., Arulampalam, V., Ahrlund-Riehter, L., and Pettersson, S. Identification of Ets-like lymphoid specific elements within the immunoglobulin heavy chain 3′ enhancer. Nucleic Acids Res., 20: 4401-4408, 1992.
40. Linderson, Y., Cross, D., Neurath, M. F., and Pettersson, S. NFE, a new transcriptional activator that facilitates p50 and c-Rel-dependent IgH 3′ enhancer activity. Eur. J. Immunol., 27: 468-475, 1997.
41. Kanda, K., Hu, H-M., Zhang, L., Grandchamps, J., and Boxer, L. M. NF-κB activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer. J. Biol. Chem., 275: 32338-32346, 2000.
42. Ji, L., Areinas, M., and Boxer, L. M. NF-κB sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma. Mol. Cell. Biol., 14: 7967-7974, 1994.
43. Phan, S. C., Feeley, B., Withers, D., and Boxer, L. M. Identification of an inducible regulator of c-myb expression during T-cell activation. Mol. Cell. Biol., 16: 2387-2393, 1996.
44. Boyd, K. E., and Farnham, P. J. Coexamination of site-specific transcription factor binding and promoter activity in living cells. Mol. Cell. Biol., 19: 8393-8399, 1999.
45. Armstrong, J. A., Bieker, J. J., and Emerson, B. M. A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro. Cell, 95: 93-104, 1998.
46. Liu, R., Liu, H., Chen, X., Kirby, M., Brown, P. O., and Zhao, K. Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell, 106: 309-318, 2001.
47. Pazin, M. J., Sheridan, P. L., Cannon, K., Cao, Z., Keck, J. G., Kadanaga, J. T., and Jones, K. A. NF-κB-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes Dev., 10: 37-49, 1996.
48. Widlak, P., Gaynor, R. B., and Garrard, W. T. In vitro chromatin assembly of the HIV-1 promoter. ATP-dependent polar repositioning of nucleosomes by Sp1 promoter. ATP-dependent polar repositioning of nucleosomes by Sp1 and NF-κB. J. Biol. Chem., 272: 17654-17661, 1997.
49. Ainbinder, E., Revach, M., Wolstein, O., Moshonov, S., Diamant, N., and Dikstein, R. Mechanism of rapid transcriptional induction of tumor necrosis factor α-responsive genes by NF-κB. Mol. Cell. Biol., 22: 6354-6362, 2002.
50. Kadam, S., McAlpine, G. S., Phelan, M. L., Kingston, R. E., Jones, K. A., and Emerson, B. M. Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes Dev., 14: 2441-2451, 2000.
51. Liu, H., Kang, H., Liu, R., Chen, X., and Zhao, K. Maximal induction of a subset of interferon target genes requires the chromatin-remodeling activity of the BAF complex. Mol. Cell. Biol., 22: 6471-6479, 2002.
52. Kadam, S., and Emerson, B. M. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol. Cell, 11: 377-389, 2003.
53. Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., and Collins, T. CREB-binding protein/p300 are trascriptional coactivators of p65. Proc. Natl. Acad. Sci. USA, 94: 2927-2932, 1997.
54. Kundu, T. K., Palhan, V. B., Wang, Z., An, W., Cole, P. A., and Roeder, R. G. Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol. Cell, 6: 551-561, 2000.
55. Zhong, H., May, M. J., Jimi, E., and Ghosh, S. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol. Cell, 9: 625-636, 2002.